PPIs Are Not Responsible for Elevating Cardiovascular Risk in Patients on Clopidogrel—A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

PPIs Are Not Responsible for Elevating Cardiovascular Risk in Patients on Clopidogrel—A Systematic Review and Meta-Analysis

Published:2018-11-19 Issue: Volume:9 Page:
ISSN:1664-042X
Container-title:Frontiers in Physiology
language:
Short-container-title:Front. Physiol.

Author:

Demcsák Alexandra,Lantos Tamás,Bálint Emese Réka,Hartmann Petra,Vincze Áron,Bajor Judit,Czopf László,Alizadeh Hussain,Gyöngyi Zoltán,Márta Katalin,Mikó Alexandra,Szakács Zsolt,Pécsi Dániel,Hegyi Péter,Szabó Imre László

Publisher

Frontiers Media SA

Subject

Physiology (medical),Physiology

Reference56 articles.

1. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents;Abraham;Circulation,2010

2. Proton pump inhibitors and other disease-based factors in the recurrence of adverse cardiovascular events following percutaneous coronary angiography: a long-term cohort;Ayub;Indian J. Gastroenterol,2016

3. Clopidogrel with or without omeprazole in coronary artery disease;Bhatt;N. Engl. J. Med,2010

4. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents;Bhatt;Circulation,2008

5. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial;Burkard;J. Intern. Med,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastroesophageal Reflux Disease;Annals of Internal Medicine;2024-08

2. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease;Nature Reviews Cardiology;2024-03-20

3. Does the long-term administration of proton pump inhibitors increase the risk of adverse cardiovascular outcomes? A ChatGPT powered umbrella review;Acta Cardiologica;2023-07-11

4. Prevalence and Safety of Prescribing PPIs with Clopidogrel in Palestine;Patient Preference and Adherence;2023-03

5. Risks of long-term use of proton pump inhibitor on ischemic vascular events: A distributed network analysis of 5 real-world observational Korean databases using a common data model;International Journal of Stroke;2022-10-27